SAVENCIA : Modalités relatives à la retransmission et à la rediffusion de l’Assemblée Générale Modalités relatives à la retransmission et à la rediffusion de l’Assemblée Générale Mixte Ordinaire et Extraordinaire de Savencia SAdu 24 avril 2025 10h30 L’Assemblée Générale fera l’objet d’une retransmission audiovisuelle en direct et d’un enregistrement qui pourra être consulté conformément aux dispositions des articles L.22-10-38-1 et R. 22-10-29-1 du code de commerce. Les actionnaires désireux d’assister à la retransmission de l’Assemblée Générale sont invités à remplir le formulaire en cl...
A director at Salter Brothers Emerging Companies Ltd bought 90,636 shares at 0.651AUD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Notification of major shareholding Park Street A/S Major shareholder Announcements Notification of major shareholding With reference to section 30 of the Danish Capital Markets Act, Park Street A/S (the "Company") hereby announces the below developments in the direct and indirect holdings of share capital and voting rights in the Company by Park Street Asset Management Ltd. On 11 April 2025, Park Street Asset Management Ltd (PSAM) completed a purchase of 2,137,939 Class A shares and 32,183,070 Class B shares at DKK11.398 per share (Closing market price as of 9 April 2025 for Class...
Swings observed in the last 10 days has been second to none. The Great Financial Crisis and Covid didn’t get us in a worst spot. Make no mistake: The markets are panicking today even more than when the world came to a COVID standstill, with the individual contributors to the vast majority of the world’s GDP locked down. How reasonable is that? Very little, in our view. The polarization of the political landscape has created a global brain freeze. Few analyses calmly assess the U.S. administrati...
Financial markets have had their wildest week for years. But for all the drama, the outlook for the global economy looks much like it did 7 days ago. James Smith reckons the craziness doesn't stop here. Buckle up and shout if you want to go faster, as our team tries to figure out where this rollercoaster journey goes in the week to come
A director at 1&1 Drillisch Ag bought 4,400,000 shares at 13.815EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
MYT Netherlands Parent B.V. (“Mytheresa”) receives final regulatory clearance to acquire YOOX NET-A-PORTER (“YNAP”) from Richemont, with closing planned for 23 April 2025 MYT Netherlands Parent B.V. (“Mytheresa”) receives final regulatory clearanceto acquire YOOX NET-A-PORTER (“YNAP”) from Richemont, with closing planned for 23 April 2025 11 April 2025 – Today, Mytheresa (NYSE:MYTE) received the unconditional merger control clearance from the European Commission for the acquisition of YNAP from Richemont (SWX:CFR), through its subsidiary Richemont Italia Holding S.P.A.. Mytheresa a...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Aviva plc 11-Apr-2025 / 14:23 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlo...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated 11-Apr-2025 / 14:25 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the truste...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc 11-Apr-2025 / 14:23 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the tr...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. 11-Apr-2025 / 14:24 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. ...
Apex Fundrock Limited (MISL) Form 8.3 - Induction Healthcare Group PLC - Opening Position Disclosure 11-Apr-2025 / 14:27 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Chelverton Asset Management (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a ...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Assura plc 11-Apr-2025 / 14:24 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settl...
Middlefield Canadian Income PCC: Net Asset Value(s) Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey with registration number 93546)Legal Entity Identifier: 2138007ENW3JEJXC8658 Net Asset Value As at the close of business on 10 April 2025 the estimated unaudited Net Asset Value per share was 116.36 pence (including accrued income), which excludes an amount of 1.375 pence per share in respect of the quarterly dividend to be paid on 30 April 2025. Investments in the Compa...
A director at Calida Holding AG bought 1,000 shares at 16.520CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements - The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses BOSTON, MASSACHUSETTS, April 11, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing novel therapies targeting hypoxia and mitochondrial dysfunction, today highlighted the historical and scientific signifi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.